US FDA’s Califf Says Publishing Complete Response Letters Could Help Fight Misinformation
Executive Summary
But the commissioner also said proponents of releasing CRs may be making too much of the idea, because there are few CRs actually issued.
You may also be interested in...
A Little Help From His Friends: Califf Requests Patients Help US FDA Fight Misinformation
The idea seems to stem from thinking that human interaction is the best way to combat rumors and false statements.
US FDA Commissioner Califf Takes On Misinformation, Starting With ‘Rumor Control’
Agency leader expects to spend about a year developing a strategy to combat misinformation. On 5 August, the agency unveiled what appears to be an early component of the initiative – a web page titled Rumor Control, with facts about the safety and components of COVID-19 vaccines.
US FDA’s 2022 Novel Agent Actions Suggest Acceleration In Use Of Complete Response Letters
COVID does not appear to be a driving factor, and letters are split almost equally between clinical and quality concerns.